A research group led by Prof. Sun Xiaobing from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, ...

AI leadership, strong growth guidance, and undervalued shares offer major upside. Click here to read my analysis.

Carillon Scout Mid Cap Fund Q3 2025 insight: mid-cap market up from AI infrastructure and Fed rate cuts. See top/bottom ...

Live Updates Get The Best Oklo Inc. Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis ...

Why Tech Unicorns Choose Adobe Creative Cloud Tech unicorns worldwide are choosing adobe creative cloud key as their go-to creative software suite. This shift to Adobe’s ecosystem isn’t random — it’s ...

Workers are under pressure to adopt AI tools, even when those tools haven’t been vetted—just in time for Cybersecurity Month.

Affinity has all the same editing tools as Affinity Photo, but with vector drawing and page layout thrown in, too. Affinity ...

Otsuka Pharma enters licensing agreement with 4D Molecular Therapeutics for ophthalmic gene therapy drug candidate, 4D-150: Tokyo Monday, November 3, 2025, 11:00 Hrs [IST] Otsuka ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

The manuscript concerns a fundamental and controversial question in Trypanosoma brucei biology and the parasite life cycle, providing further evidence that slender bloodstream forms can indeed infect ...

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to have dosed 30 ...